ESVS focused guideline update for intermittent claudication: paclitaxel coated balloons and stents may be considered only for selected re-stenosis, after discussing uncertain long term safety; SWEDEPAD 2 showed no quality of life or re-intervention benefit at 12 months.
Guideline
Nordanstig et al. Editor's Choice - Focused Update on Paclitaxel Coated Technologies, from the 2024 European Society for Vascular Surgery (ESVS) Guidelines on the Management of Asymptomatic Peripheral Arterial Disease and Intermittent Claudication